TickerGuard
Buy Day today: Neutral (60) Mixed market breadth · no major macro event
ANNX

Annexon Inc

Healthcare · Biotechnology

4.20$ -0.2% vs. previous close Closing price · As of: Sep 21, 2026

Statements

Balance Sheet

All figures as a percentage of total assets in the same period.

Tick rows to compare them in a chart (up to 4)

Balance Sheet ANNX
Line item 2017 2018 2019 2020 2021 2022 2023 2024 2025
100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0%
62.6% 94.9% 91.0% 99.5% 86.3% 87.0% 88.6% 90.4% 87.3%
37.9% 91.7% 88.0% 75.5% 26.1% 49.1% 75.6% 14.1% 58.4%
37.9% 91.7% 88.0% 98.7% 84.6% 85.1% 87.2% 89.1% 85.9%
7.4% 0.5% 0.2% 0.0%
0.0%
36.0% 4.9% 4.3% 0.5% 13.3% 5.9%
690.9% 21.3% 12.8% 3.3% 19.2% 18.9% 15.8% 16.3% 23.7%
37.3% 6.9% 9.9% 3.0% 7.6% 7.8% 6.0% 8.7% 15.4%
0.1% 0.4% 0.5% 0.7% 0.7% 1.0%
19.5% 2.6% 4.8% 1.0% 3.9% 2.6% 1.8% 3.0% 5.4%
-590.9% 78.7% 87.2% 96.7% 80.8% 81.1% 84.2% 83.7% 76.3%
-602.1% -135.8% -205.6% -46.6% -103.2% -153.7% -192.3% -203.0% -330.5%
488.7% 23.8% 76.6% 4.8% 13.3% 19.2% 25.4% 39.3% 55.9%

Data as of: September 21, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?